Harlan S Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

Harlan S Robins is Chief Scientific Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1.02 Million shares of ADPT, which is worth approximately $5.42 Million. The most recent transaction as insider was on Mar 04, 2024, when has been sold 354,610 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.02M

0% 3M change

53.2% 12M change

Total Value Held $5.42 Million

HARLAN S ROBINS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2024	BUY Grant, award, or other acquisition	-	354,610 Added 25.78%	1,021,180 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	354,610 Added 34.73%	666,570 Common Stock
Mar 07 2022	SELL Open market or private sale	$54,249 $12.01 p/Share	4,517 Reduced 1.43%	311,960 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	247,117 Added 43.85%	316,477 Common Stock
Nov 18 2021	SELL Open market or private sale	$9,408 $31.36 p/Share	300 Reduced 0.43%	69,360 Common Stock
Nov 18 2021	BUY Exercise of conversion of derivative security	$1,965 $6.55 p/Share	300 Added 0.43%	69,660 Common Stock
Nov 17 2021	SELL Open market or private sale	$118,585 $32.05 p/Share	3,700 Reduced 5.06%	69,360 Common Stock
Nov 17 2021	BUY Exercise of conversion of derivative security	$24,235 $6.55 p/Share	3,700 Added 4.82%	73,060 Common Stock
Oct 21 2021	SELL Open market or private sale	$124,801 $33.73 p/Share	3,700 Reduced 5.06%	69,360 Common Stock
Oct 21 2021	BUY Exercise of conversion of derivative security	$24,235 $6.55 p/Share	3,700 Added 4.82%	73,060 Common Stock
Oct 20 2021	SELL Open market or private sale	$124,727 $33.71 p/Share	3,700 Reduced 5.06%	69,360 Common Stock
Oct 20 2021	BUY Exercise of conversion of derivative security	$24,235 $6.55 p/Share	3,700 Added 4.82%	73,060 Common Stock
Oct 19 2021	SELL Open market or private sale	$126,654 $33.33 p/Share	3,800 Reduced 5.19%	69,360 Common Stock
Oct 19 2021	BUY Exercise of conversion of derivative security	$24,890 $6.55 p/Share	3,800 Added 4.94%	73,160 Common Stock
Oct 08 2021	SELL Open market or private sale	$128,379 $32.96 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Oct 08 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Oct 07 2021	SELL Open market or private sale	$128,886 $33.09 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Oct 07 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Oct 06 2021	SELL Open market or private sale	$125,692 $32.27 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Oct 06 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Sep 15 2021	SELL Open market or private sale	$143,648 $36.88 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Sep 14 2021	SELL Open market or private sale	$143,842 $36.93 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Sep 13 2021	SELL Open market or private sale	$146,608 $37.64 p/Share	3,895 Reduced 5.32%	69,360 Common Stock

HSR

Harlan S Robins

Chief Scientific Officer

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account